IRF-4 Suppresses BCR/ABL Transformation of Myeloid Cells in a DNA Binding-independent Manner
Authors:
Open Access
- 1 January 2012
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (3) , 1770-1778
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesisBlood, 2010
- ERK activation drives intestinal tumorigenesis in Apcmin/+ miceNature Medicine, 2010
- IRF4: Immunity. Malignancy! Therapy?Clinical Cancer Research, 2009
- Toll-like receptors and cancerNature Reviews Cancer, 2008
- IRF-4-Binding Protein Inhibits Interleukin-17 and Interleukin-21 Production by Controlling the Activity of IRF-4 Transcription FactorImmunity, 2008
- IRF-4 functions as a tumor suppressor in early B-cell developmentBlood, 2008
- Interferon regulatory factor 4 and 8 in B-cell developmentTrends in Immunology, 2008
- Toll-like receptors: lessons to learn from normal and malignant human B cellsBlood, 2008
- IRF4 addiction in multiple myelomaNature, 2008
- Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre–B-cell receptor and promote cell-cycle withdrawal in pre–B-cell developmentBlood, 2008